Rocío Granda‐Díaz

Author

Rocío Granda‐Díaz

Instituto de Investigación Sanitaria del Principado de Asturias ORCID

Also Known As

R. Granda-Diaz, R. Granda-Díaz, Rocio Granda-Diaz, Rocio Granda-Díaz, Roco Granda-Daz, Rocío Granda-Diaz, Rocío Granda-Díaz, Rocío Granda‐Díaz

Publications

591

Citations

H-Index

Concepts

All Affiliations

Instituto de Investigación Sanitaria del Principado de Asturias Universidad de Oviedo Centro de Investigación Biomédica en Red de Cáncer Instituto de Salud Carlos III Hospital Universitario Central de Asturias

About

Rocío Granda‐Díaz is an author at Instituto de Investigación Sanitaria del Principado de Asturias specializing in medicine, tumor microenvironment, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	260
2	Cell Biology	6	6	202
3	Pathology	4	4	179
4	Immunology	2	2	75
5	Health Sciences	1	1	24

Rocío Granda‐Díaz

Publications

481

Citations

H-Index

Page 1

	Year	Citations
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib Irati Garmendia, María J. Pajares, Francisco Hermida‐Prado, American Journal of Respiratory and Critical Care Medicine	2019	68
Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets Saúl Álvarez–Teijeiro, Cristina García–Inclán, M. Ángeles Villaronga, Cancers Chemoprevention StrategyCancer Stem CellPathologyCancer-associated FibroblastsCancer Stem Properties	2018	60
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas Mario Sánchez‐Canteli, Rocío Granda‐Díaz, Nagore del Rio-Ibisate, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityPathology	2020	58
Deciphering the Molecular Basis of Melatonin Protective Effects on Breast Cells Treated with Doxorubicin: TWIST1 a Transcription Factor Involved in EMT and Metastasis, a Novel Target of Melatonin Javier Menéndez-Menéndez, Francisco Hermida‐Prado, Rocío Granda‐Díaz, Cancers Transcription Factor InvolvedBreast OncologyMelatonin Protective EffectsMedicineCancer Initiation	2019	46
SOX2 Expression Is an Independent Predictor of Oral Cancer Progression Juan Carlos de Vicente, Paula Donate-Pérez del Molino, Juan P. Rodrigo, Journal of Clinical Medicine Tumor BiologyOral CarcinogenesisOncologyOral Potentially Malignant DisordersOncogenic Agent	2019	44
The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma Lucia Morgado-Palacin, Jessie Brown, Thomas F. Martínez, Nature Communications	2023	34
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas Daniel Pedregal‐Mallo, Francisco Hermida‐Prado, Rocío Granda‐Díaz, Cancers	2020	32
Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b Saúl Álvarez–Teijeiro, Sofía T. Menéndez, M. Ángeles Villaronga, Scientific Reports	2017	29
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042 Francisco Hermida‐Prado, M. Ángeles Villaronga, Rocío Granda‐Díaz, Journal of Clinical Medicine Chemoprevention StrategyTreatment ResistanceTumor BiologyOncologySfk Inhibitors	2019	24
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients Francisco Hermida‐Prado, Sofía T. Menéndez, Pablo Albornoz-Afanasiev, Journal of Clinical Medicine	2018	22

Page 1